Social Behaviour Risk Factors for Drug Resistant Tuberculosis in Mainland China: A Meta-Analysis
Tóm tắt
OBJECTIVE: To determine risk factors associated with drug resistant tuberculosis (TB) in mainland China. METHODS: PubMed and Chinese BioMedical databases were searched. Cohort, case—control and cross-sectional studies providing effect estimates of risk factors for any-drug resistant or multidrug resistant (MDR) TB were included. RESULTS: The meta-analysis included 16 studies. Any-drug resistant TB was significantly associated with poor quality directly observed treatment, short-course (DOTS) (odds ratio [OR] 2.65, 95% confidence interval [CI] 1.22, 5.79), long term illness > 1 year (OR 2.71, 95% CI 1.34, 5.48), poor treatment adherence (OR 2.00, 95% CI 1.17, 3.40), previous treatment (OR 4.54, 95% CI 2.71, 7.61) and age 40 – 60 years (OR 1.62, 95% CI 1.10, 2.38). MDR-TB was significantly associated with poor quality DOTS (OR 1.84, 95% CI 1.36, 2.49), poor treatment adherence (OR 4.39, 95% CI 2.97, 6.50), previous treatment (OR 3.83, 95% CI 2.12, 6.89) and poverty (OR 1.87, 95% CI 1.38, 2.52). CONCLUSIONS: Previous treatment, poor quality DOTS, poor treatment adherence, long term illness, age 40 – 60 years and poverty are associated with a greater risk of drug resistant TB in mainland China.
Từ khóa
Tài liệu tham khảo
2003, Diagnostic Atlas of Intrathoracic Tuberculosis in Children: A Guide for Low Income Countries
World Health Organization, 2009, Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009
World Health Organization, 2010, Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response
Ministry of Health of the People's Republic of China, 2010, Nationwide Anti-tuberculosis Drug Resistant Baseline Surveillance in China (2007–2008)
Wright A, 2006, MMWR, 55, 301
Shen X, 2009, Int J Tuberc Lung Dis, 13, 253
Wei CY, 2007, Mod Prev Med, 34, 3275
Zhou LX, 2009, A Case—Control Study on Risk Factor for Acquired Drug Resistant Tuberculosis of Adult
Zhu JF, 2009, Zhejiang J Prev Med, 21, 6
Zheng Z, 2004, Epidemiological Studies on the Prevalence Rate and the Impact Factors of Drug Resistant Tuberculosis Among Pulmonary Tuberculosis Inpatients
Yang BF, 2004, Determinants and Molecular Epidemiology of Drug-resistant Tuberculosis in Rural Area of North Jiangsu Province
Zhang H, 2009, J Chin Antituberc Assoc, 31, 218
Lin H, 2008, Acta Academiae Medicinae Militaris Tertiae, 30, 1183
Chen J, 2007, Preliminary Study on Social Behavior Factors of TB Patients and Genotyping of Mycobacterium tuberculosis
Wang WH, 2005, Study of Risk Factors of Multi-drug Resistant Pulmonary Tuberculosis and the Quality of Life of Patients
World Health Organization, 1995, WHO Report on the Tuberculosis Epidemic, 1995. Stop TB at the Source
Li H, 2010, J Clin Pulm Med, 15, 367
Xu B, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, 31, 525
Zhang M, 2010, Chin J Public Health, 26, 1439
Xu L, 2010, China Trop Med, 10, 1333
Sun B, 2008, Chin Prim Health Care, 22, 66
Moniruzzaman A, 2006, Int J Tuberc Lung Dis, 10, 631
Espinal MA, 2001, Int J Tuberc Lung Dis, 5, 887
Law WS, 2008, Int J Tuberc Lung Dis, 12, 1065
Mitchison DA, 1998, Int J Tuberc Lung Dis, 2, 10
World Health Organization, 2004, Anti-tuberculosis Drug Resistance in the World, Report No. 3
World Health Organization, 2006, The Stop TB Strategy: Building on and Enhancing DOTS to Meet the TB-related Millennium Development Goals
Zhang LX, 2000, Int J Tuberc Lung Dis, 4, 904
Liu YN, 2011, J Capital Med Univ, 32, 125
2002, Chin J Tuberc Respir Dis, 25, 3